Psi Cro Pharma India Private Limited, a active foreign private limited company, was established on 05 September 2008 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999KA2008FTC047698. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Nikolay Sinakevich (Director), Albertine Varone (Director), Andrey Kozhemyakin (Director). Past directors included Albertine Varone, Andrey Kozhemyakin, Martin Schmidt. Its latest AGM occurred on 30 June 2025, with the balance sheet filed on 31 December 2024. It is based at 2Nd Floor , Doddamane Building, No.19/1 Vittal Mallya Road, Bangalore North, Karnataka, 560001.
U74999KA2008FTC047698
047698
05 September 2008
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Psi Cro Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikolay Sinakevich | Director | 23 Dec 2008 | Current |
| Albertine Varone | Director | 19 Apr 2021 | Current |
| Andrey Kozhemyakin | Director | 19 Apr 2021 | Current |
| Srikanth Narasimhan | Director | 30 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2021 | Past |
| Pramod Abcsdd | Managing Director | 29 Sep 2020 | Past |
| Pramod Abcsdd | Director | 24 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Psi Cro Pharma India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.36% increase. The company also saw a slight improvement in profitability, with a 1.78% increase in profit. The company's net worth Soared by an impressive increase of 15.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Psi Cro Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Psi Cro Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Psi Cro Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psi Cro Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Psi Cro Pharma India Private Limited last Annual general meeting of members was held on 30 Jun 2025 as per latest MCA records. was completed.
Psi Cro Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Bangalore. was recorded as a recent event.
The activity Albertine Varone was appointed as a Director was appointed as a Director on 19 Apr 2021 & has been associated with this company since 4 years 7 months . was completed.
Progress on Andrey Kozhemyakin was appointed as a Director was appointed as a Director on 19 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Progress on Srikanth Narasimhan was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 5 months . was documented.
Nikolay Sinakevich was appointed as a Director was appointed as a Director on 23 Dec 2008 & has been associated with this company since 16 years 11 months . was recorded as a recent event.
The CIN of Psi Cro Pharma India Private Limited is U74999KA2008FTC047698.
Psi Cro Pharma India Private Limited is headquartered at 2Nd Floor , Doddamane Building, No.19/1 Vittal Mallya Road, Bangalore North, Karnataka, 560001.
Psi Cro Pharma India Private Limited was incorporated on 05 September 2008.
The current directors of Psi Cro Pharma India Private Limited are
The primary industry of Psi Cro Pharma India Private Limited is Professional, Scientific And Technical.
Psi Cro Pharma India Private Limited is unlisted.
The authorized capital of Psi Cro Pharma India Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Psi Cro Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX